Next Article in Journal
Ultrastructural Characterization of the Frontal Lobe in the Case of Human Herpes Virus-6 Infection
Previous Article in Journal
Ubiquity, Diversity, and Genomic Complexity of Cyanophages in Freshwater Environments
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Ts2631 Endolysin from the Extremophilic Thermus scotoductus Bacteriophage vB_Tsc2631 as an Antimicrobial Agent against Gram-Negative Multidrug-Resistant Bacteria †

by
Magdalena Plotka
1,*,
Malgorzata Kapusta
2,
Sebastian Dorawa
1,
Anna-Karina Kaczorowska
3 and
Tadeusz Kaczorowski
1,*
1
Laboratory of Extremophiles Biology, Department of Microbiology, Faculty of Biology, University of Gdansk, 80-822 Gdansk, Poland
2
Department of Plant Cytology and Embryology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland
3
Collection of Plasmids and Microorganisms, Faculty of Biology, University of Gdansk, 80-822 Gdansk, Poland
*
Authors to whom correspondence should be addressed.
Presented at Viruses 2020-Novel Concepts in Virology, Barcelona, Spain, 5–7 February 2020.
Proceedings 2020, 50(1), 106; https://doi.org/10.3390/proceedings2020050106
Published: 26 June 2020
(This article belongs to the Proceedings of Viruses 2020—Novel Concepts in Virology)

Abstract

:
Bacteria that thrive in extreme conditions and the bacteriophages that infect them are sources of valuable enzymes that are resistant to denaturation at high temperatures. Many of these heat-stable proteins are useful for biotechnological applications; nevertheless, none have been utilized as antibacterial agents. Here, we demonstrate the bactericidal potential of Ts2631 endolysin from the extremophilic bacteriophage vB_Tsc2631, which infects Thermus scotoductus, against the alarming multidrug-resistant clinical strains of Acinetobacter baumannii, Pseudomonas aeruginosa, and pathogens from the Enterobacteriaceae family. A 2–3.7 log reduction in the bacterial load was observed in antibacterial tests against A. baumannii and P. aeruginosa after 1.5 h. The Ts2631 activity was further enhanced by ethylenediaminetetraacetic acid (EDTA), a metal ion chelator (4.2 log reduction in carbapenem-resistant A. baumannii) and, to a lesser extent, by malic acid and citric acid (2.9 and 3.3 log reductions, respectively). The EDTA/Ts2631 combination reduced all pathogens of the Enterobacteriaceae family, particularly multidrug-resistant Citrobacter braakii, to levels below the detection limit (>6 log); these results indicate that Ts2631 endolysin could be useful to combat Gram-negative pathogens. The investigation of A. baumannii cells treated with Ts2631 endolysin variants under transmission electron and fluorescence microscopy demonstrates that the intrinsic antibacterial activity of Ts2631 endolysin is dependent on the presence of its N-terminal tail.
The whole manuscript can be found at:
Plotka, M.; Kapusta, M.; Dorawa, S.; Kaczorowska, A.-K.; Kaczorowski, T. Ts2631 Endolysin from the Extremophilic Thermus scotoductus Bacteriophage vB_Tsc2631 as an Antimicrobial Agent against Gram-Negative Multidrug-Resistant Bacteria. Viruses 2019, 11, 657. doi: 10.3390/v11070657

Share and Cite

MDPI and ACS Style

Plotka, M.; Kapusta, M.; Dorawa, S.; Kaczorowska, A.-K.; Kaczorowski, T. Ts2631 Endolysin from the Extremophilic Thermus scotoductus Bacteriophage vB_Tsc2631 as an Antimicrobial Agent against Gram-Negative Multidrug-Resistant Bacteria. Proceedings 2020, 50, 106. https://doi.org/10.3390/proceedings2020050106

AMA Style

Plotka M, Kapusta M, Dorawa S, Kaczorowska A-K, Kaczorowski T. Ts2631 Endolysin from the Extremophilic Thermus scotoductus Bacteriophage vB_Tsc2631 as an Antimicrobial Agent against Gram-Negative Multidrug-Resistant Bacteria. Proceedings. 2020; 50(1):106. https://doi.org/10.3390/proceedings2020050106

Chicago/Turabian Style

Plotka, Magdalena, Malgorzata Kapusta, Sebastian Dorawa, Anna-Karina Kaczorowska, and Tadeusz Kaczorowski. 2020. "Ts2631 Endolysin from the Extremophilic Thermus scotoductus Bacteriophage vB_Tsc2631 as an Antimicrobial Agent against Gram-Negative Multidrug-Resistant Bacteria" Proceedings 50, no. 1: 106. https://doi.org/10.3390/proceedings2020050106

Article Metrics

Back to TopTop